{"id":705473,"date":"2026-07-29T05:06:03","date_gmt":"2026-07-29T05:06:03","guid":{"rendered":"https:\/\/microscopemedia.com\/?p=705473"},"modified":"2026-07-29T05:06:03","modified_gmt":"2026-07-29T05:06:03","slug":"de-la-diagnostic-avansat-la-tratament-tintit-ce-este-abordarea-teranostica-si-ce-beneficii-ofera-p","status":"publish","type":"post","link":"https:\/\/microscopemedia.com\/?p=705473","title":{"rendered":"De la diagnostic avansat la tratament \u021bintit: ce este abordarea teranostic\u0103 \u0219i ce beneficii ofer\u0103 (P)"},"content":{"rendered":"<div class=\"sgb-google-buttons\">\n<div class=\"display-flex justify-center google-logo\"><img decoding=\"async\" loading=\"lazy\" class=\"mg-x-auto\" width=\"30\" height=\"30\" src=\"https:\/\/microscopemedia.com\/wp-content\/uploads\/2026\/07\/de-la-diagnostic-avansat-la-tratament-tintit-ce-este-abordarea-teranostica-si-ce-beneficii-ofera-p.png\" alt><\/div>\n<\/p><\/div>\n<p id=\"p-0\">De asemenea, \u00een cazuri selectate de cancer de prostat\u0103, atunci c\u00e2nd boala este agresiv\u0103 sau c\u00e2nd tratamentele indicate nu au oferit rezulatele dorite, o abordare avansat\u0103 \u00een medicina modern\u0103, numit\u0103 abordarea teranostic\u0103, poate oferi beneficii unor pacien\u021bi atent selecta\u021bi, contribuind la controlul bolii \u0219i, \u00een anumite situa\u021bii, la prelungirea supravie\u021buirii. Aceasta folose\u0219te aceea\u0219i \u021bint\u0103 molecular\u0103 \u2013 <a href=\"https:\/\/www.sanador.ro\/psma\">PSMA<\/a> (antigenul membranar specific prostatic) \u2013 pentru imagistic\u0103 avansat\u0103, stadializare\/restadializare \u0219i, \u00een unele cazuri, pentru tratament \u021bintit.<\/p>\n<p id=\"p-1\">PSMA este o protein\u0103 transmembranar\u0103 prezent\u0103 \u00een cantitate crescut\u0103 pe suprafa\u021ba multor celule tumorale din cancerul de prostat\u0103, iar examenul PET-CT PSMA permite identificarea imagistic\u0103 a leziunilor care exprim\u0103 aceast\u0103 \u021bint\u0103.<\/p>\n<p id=\"p-2\">Scanarea PET-CT este efectuat\u0103 dup\u0103 administrarea intravenoas\u0103 a unui radiotrasor PSMA, care se leag\u0103 de celulele care exprim\u0103 \u00een cantitate crescut\u0103 acest antigen, \u0219i permite echipei medicale s\u0103 localizeze cu acurate\u021be leziunile sau focarele suspecte, inclusiv unele metastaze la distan\u021b\u0103.<\/p>\n<p id=\"p-3\">Prin urmare, aceast\u0103 investiga\u021bie avansat\u0103 de medicin\u0103 nuclear\u0103 contribuie la stadializarea primar\u0103 a unui cancer de prostat\u0103, dar \u0219i la restadializare, atunci c\u00e2nd nivelul PSA cre\u0219te dup\u0103 administrarea unui <a href=\"https:\/\/www.sanador.ro\/centrul-oncologic-si-tratament-cancer\">tratament pentru cancer<\/a>, suger\u00e2nd o recidiv\u0103 biochimic\u0103, iar medicul poate urm\u0103ri localizarea eventualelor focare de boal\u0103.<\/p>\n<p id=\"p-4\">Examinarea nu \u00eenlocuie\u0219te alte investiga\u021bii recomandate pentru diagnostic, nici biopsia de prostat\u0103, ci vine \u00een completarea acestora, oferind informa\u021bii suplimentare atunci c\u00e2nd exist\u0103 indica\u021bie \u00een acest sens, date care contribuie la alegerea strategiei terapeutice.<\/p>\n<p id=\"p-5\">\u00cen abordarea teranostic\u0103, PET-CT PSMA ajut\u0103 la identificarea leziunilor PSMA-pozitive, iar tratamentul PSMA cu lute\u021biu-177 folose\u0219te aceste date pentru administrarea \u021bintit\u0103 a radia\u021biei c\u0103tre celule tumorale care exprim\u0103 PSMA.<\/p>\n<p id=\"p-6\">Un <a href=\"https:\/\/www.sanador.ro\/terapie-psma-lutetiu-177\">tratament PSMA<\/a> poate fi recomandat de comisia oncologic\u0103 multidisciplinar\u0103 \u00een cazuri selectate de cancer de prostat\u0103 metastatic rezistent la castrare, PSMA-pozitiv, dup\u0103 evaluarea tratamentelor sistemice urmate anterior, a extensiei bolii, a analizelor \u0219i a st\u0103rii generale a pacientului.<\/p>\n<p id=\"p-7\">Acest tratament \u021bintit implic\u0103 administrarea intravenoas\u0103, \u00een condi\u021bii speciale de radioprotec\u021bie asigurate de o sec\u021bie de terapie izotopic\u0103, a unui radioligand, adic\u0103 o molecul\u0103 care se leag\u0103 de PSMA, cuplat\u0103 cu izotopul radioactiv lute\u021biu-177.<\/p>\n<p id=\"p-8\">\u00cen acest fel, substan\u021ba radioactiv\u0103 este administrat\u0103 sistemic \u0219i ajunge la leziunile care exprim\u0103 PSMA, unde elimin\u0103 radia\u021bie local, cu scopul de a distruge celulele tumorale sau de a \u00eencetini evolu\u021bia bolii, limit\u00e2nd pe c\u00e2t posibil expunerea \u021besuturilor s\u0103n\u0103toase.<\/p>\n<p id=\"p-9\">R\u0103spunsul la tratament este urm\u0103rit prin monitorizarea nivelului PSA, evaluarea simptomelor, prin analize de laborator \u0219i imagistic\u0103 medical\u0103. Prin urmare, \u00een abordarea teranostic\u0103, evaluarea imagistic\u0103 de precizie \u0219i tratamentul \u021bintit sunt integrate \u00eentr-un parcurs medical complet, cu beneficii semnificative pentru pacien\u021bii eligibili.<\/p>\n<p id=\"p-10\">Examenul PET-CT PSMA \u0219i tratamentul cu lute\u021biu-177 sunt disponibile, \u00een premier\u0103 pentru Rom\u00e2nia, la Centrul Oncologic SANADOR, care asigur\u0103 o abordare integrat\u0103, multimodal\u0103, pentru pacien\u021bii cu cancer de prostat\u0103, \u00een func\u021bie de indica\u021bia stabilit\u0103 pentru fiecare \u00een parte.<\/p>\n<p id=\"p-11\">Pentru diagnostic, pacien\u021bii beneficiaz\u0103 la SANADOR de examen RMN multiparametric de prostat\u0103 \u0219i de punc\u021bie prostatic\u0103 de fuziune, iar ulterior, conform recomand\u0103rii medicale, de examen PET-CT PSMA sau de scintigrafie osoas\u0103, pentru stadializare.<\/p>\n<p id=\"p-12\">Tratamentul este personalizat \u0219i poate include, \u00een func\u021bie de caz, interven\u021bie de chirurgie oncologic\u0103 realizat\u0103 la Spitalul Clinic SANADOR, radioterapie, chimioterapie, terapii \u021bintite, hormonoterapie sau tratament cu lute\u021biu-177. Terapia cu radioizotopi, atunci c\u00e2nd este indicat\u0103, se desf\u0103\u0219oar\u0103 \u00een condi\u021bii controlate pe Sec\u021bia de Terapie Izotopic\u0103 a Centrului Oncologic SANADOR, special amenajat\u0103 pentru radioprotec\u021bie.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>De asemenea, \u00een cazuri selectate de cancer de prostat\u0103, atunci c\u00e2nd boala este agresiv\u0103 sau c\u00e2nd tratamentele indicate nu au oferit rezulatele dorite, o abordare avansat\u0103 \u00een medicina modern\u0103, numit\u0103 &hellip; <a href=\"https:\/\/microscopemedia.com\/?p=705473\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":705474,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/705473"}],"collection":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=705473"}],"version-history":[{"count":0,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/705473\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/media\/705474"}],"wp:attachment":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=705473"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=705473"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=705473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}